Kerry Tucker
Psychiatric/Mental Health · Shepherdstown, WVNPI 1699383414
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 28.9% of the total. Reporting peaked in 2024 at $1,230 and has fallen 56.3% since, to $537 in 2025. Among psychiatric/mental health clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$824
- Teva Pharmaceuticals USA, Inc.$282
- Alkermes, Inc.$232
- Supernus Pharmaceuticals, Inc.$192
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$183
- plus $834 from 11 others
What the payments were for
- Food & beverage$3,581100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $1,034 |
| Neurocrine Biosciences, Inc. | 34 | $824 |
| Teva Pharmaceuticals USA, Inc. | 11 | $282 |
| Alkermes, Inc. | 12 | $232 |
| Supernus Pharmaceuticals, Inc. | 10 | $192 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $183 |
| Sunovion Pharmaceuticals Inc. | 9 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $151 |
| Corium, LLC | 7 | $122 |
| Johnson & Johnson | 4 | $119 |
| Indivior Inc. | 3 | $113 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Biogen | 2 | $31 |
| Gilead | 1 | $30 |
| Ironshore Pharmaceuticals Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,581 in reported general payments places this provider in the 90th percentile of 142 psychiatric/mental health providers in West Virginia.
See all psychiatric/mental health providers in West Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 169 | $10,729 |
| Bupropion XlBupropion Hcl | 22 | $2,492 |
| Lisdexamfetamine Dimesylate | 11 | $1,547 |
| Risperidone OdtRisperidone | 12 | $1,228 |
| Fluvoxamine Maleate | 17 | $737 |
| Olanzapine | 13 | $502 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 22 | $458 |
| Risperidone | 25 | $434 |
| Trazodone Hcl | 50 | $418 |
| Lamotrigine | 14 | $395 |
| Buprenorphine Hcl | 50 | $386 |
| Buspirone Hcl | 23 | $369 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $335 |
| Prazosin Hcl | 20 | $321 |
| Methylphenidate Hcl | 15 | $283 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Shepherdstown
- Jeremy SchreiberWheeling$1.7M
- Kimberly RittenhouseParkersburg$7K
- Michael SkaggsRipley$7K
- Larry RobertsonHuntington$6K
- Gwendolyn HuffmanSummersville$6K
- Summer DevolParkersburg$5K
- Osric Malone-PrioleauSaint Marys$5K
- Mercedes WeikleFort Gay$5K
- Shannon PembertonBarboursville$4K
- Cathy McGeeParkersburg$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.